A mid-stage trial of 4D Molecular Therapeutics gene therapy for eye disease ... in the 12 months after administration. Two-thirds (63%) of the patients did not need any Eylea injections at all ...

Regeneron and Bayer's efforts to defend their lucrative eye disease therapy Eylea from competition have ... (DME), and diabetic retinopathy (DR), after rejecting the drug in June due to quality ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

No eyes received pressure-lowering medication or anterior chamber paracentesis before or after the injection. The Tonopen (Reichert Technologies, New York, NY) was used for IOP measurements to ...

A MUM of two told last night how her quest for a bigger bottom left her a quadruple amputee – and 24 hours from death. Apryl Michelle Brown had black-market silicone injections which turned out ...